Does right atrial enlargement predict an increased risk of HF, stroke, systemic embolization, or death in patients with non-valvular atrial fibrillation?
Right atrial enlargement serves as an independent predictor of adverse cardiovascular outcomes in patients with non-valvular atrial fibrillation.
RA enlargement was independently associated with an increased risk of HF, stroke, systemic embolization or death in patients with non-valvular AF, suggesting that RA volume can be helpful in assessing future cardiovascular risk in this population.
Ko et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: